🇺🇸 FDA

Company profile · Sponsor

Sun

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

CC1B0C3 · NMPA pharma CN
Pipeline
7
Drugs
0
Patents
0

Quick answer

Sun (CC1B0C3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CC1B0C3
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (7)

Search pipeline →

  1. Carrellizumab + Capecitabine

    Sun

    Breast Neoplasms

    phase 3 small molecule active

    1 trial

  2. Fulvestrant combined with Pyrotinib

    Sun

    Breast Cancer

    phase 3 small molecule active

    1 trial

  3. Trastuzumab and neratinib

    Sun

    Early-stage Breast Cancer

    phase 3 small molecule active

    1 trial

  4. Donepezil Hydrochloride

    Sun

    Radiation Injuries

    phase 2 small molecule active

    1 trial

  5. Niraparib

    Sun

    Platinum-resistant Recurrent Clear Cell Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  6. Pregabalin

    Sun

    Neuropathic Pain

    phase 2 small molecule completed

    1 trial

  7. Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

    Sun

    Breast Cancers

    small molecule active

    1 trial

Frequently asked questions

What is Sun?

Sun (CC1B0C3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Sun sponsor?

We track 7 ClinicalTrials.gov-linked programs for Sun, including Carrellizumab + Capecitabine and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sun company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.